Jump to main content
Jump to site search

Issue 24, 2013
Previous Article Next Article

Design of a platinum–acridine–endoxifen conjugate targeted at hormone-dependent breast cancer

Author affiliations

Abstract

The synthesis of a novel pharmacophore comprising a DNA-targeted platinum–acridine hybrid agent and estrogen receptor-targeted 4-hydroxy-N-desmethyltamoxifen (endoxifen) using carbamate coupling chemistry and its evaluation in breast cancer cell lines are described.

Graphical abstract: Design of a platinum–acridine–endoxifen conjugate targeted at hormone-dependent breast cancer

Back to tab navigation

Supplementary files

Article information


Submitted
14 Dec 2012
Accepted
06 Feb 2013
First published
07 Feb 2013

Chem. Commun., 2013,49, 2415-2417
Article type
Communication

Design of a platinum–acridine–endoxifen conjugate targeted at hormone-dependent breast cancer

S. Ding, X. Qiao, G. L. Kucera and U. Bierbach, Chem. Commun., 2013, 49, 2415
DOI: 10.1039/C3CC38957J

Social activity

Search articles by author

Spotlight

Advertisements